In a pan-cancer analysis, 67% of primary tumors have a high ERBB2 gene copy number, and 31% of primary tumors present a low level of ERBB2 compared with their non-tumor tissues in the TCGA database. This evidence concerns the gene ERBB2 and neoplasm.